Elias Almeida Silva Barbosa

Elias Almeida Silva Barbosa

Auto-generated profile, based on publicly available information

Elias Almeida Silva Barbosa

University Federal of Pernambuco (UFPE)- Center of bioscience (CB)- Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
ASAlan Chaves dos Santos
Alan Chaves dos Santos
PTPaula Jaeger Tenorio
Paula Jaeger Tenorio
EBElias Almeida S. Barbosa
Elias Almeida S. Barbosa
GSGustavo Fonseca de Albuquerque Souza
Gustavo Fonseca de Albuquerque Souza
GPGabriella de Almeida Figueredo Praciano
Gabriella de Almeida Figueredo Praciano
Alex Sandro Rolland SouzaAlex Sandro Rolland Souza
Alex Sandro Rolland Souza
Objectives: to determine the frequency of stress, anxiety, and depression symptoms in symptomatic patients for COVID-19. To evaluate the associated factors involved in these variants. Methods: between May/June of 2020, it was conducted a prospective cross-section study with symptomatic participants for COVID-19 (n=300). It was applied an online questionnaire and the DASS-21 to evaluate the mental health of participants. Results: it was observed that 28.6%, 29.7% and 27% of the participants showed severe/extreme levels symptoms of stress, anxiety, and depression, respectively. The testing for COVID-19 application had constituted a protective factor for the development of psychiatric morbidity, once it had shown significant association in the low frequencies of severe/extreme depression [Odds Ratio (OR)]= 0.26; p=0.002) and stress (OR=0.39; p=0.01). Conclusion: individuals that are symptomatic for COVID-19 are a vulnerable group that may present high symptomatology for depression, anxiety, and stress. The identification of psychiatric morbidity frequency and its associated factors may contribute for the development of mental health strategies aiming at the prevention and mitigation of psychological impact in COVID-19 symptomatic population during the pandemic.

25 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PBPriscila Bezerra
Priscila Bezerra
FNFernanda Gabriella de Siqueira Barros Nogueira
Fernanda Gabriella de Siqueira Barros Nogueira
ASAlan Chaves dos Santos
Alan Chaves dos Santos
ALAnna Katharina Souza Lima
Anna Katharina Souza Lima
DRDavi Emanuel Ribeiro
Davi Emanuel Ribeiro
CCClístenes Crístian de Carvalho
Clístenes Crístian de Carvalho
Background COVID-19 in pregnant women has been suggested to impair maternal-fetal and neonatal outcomes. We then designed the present systematic review with meta-analysis to evaluate the repercussion of such disease over maternal fetal and neonatal mortality, need for intensive care, way of delivery, premature delivery, birth weight, Apgar score, presence of intrauterine growth restriction (IGR), and presence of amniotic fluid change. Methods We will conduct a computerized search through MEDLINE/PubMed, LILACS/BIREME, Web of science, Biorxiv, Medrxiv, and Embase on July 23, 2020. We will include cohort and case-control studies fully reported comparing pregnant women with COVID-19 with those not affected by the disease for maternal fetal and neonatal mortality, need for intensive care, way of delivery, premature delivery occurrence, birth weight, Apgar scores, presence of intrauterine growth restriction, and presence of amniotic fluid change. Three doubles of reviewers will perform in duplicate and independently all steps on screening, risk of bias judgments, and data extraction with ability to discuss disagreements with supervising authors. Pooled effects will be estimated by both fixed and random-effects models and presented according to qualitative and quantitative heterogeneity assessment. Sensitivity analyses will be performed as well as a priori subgroup, meta-regression and multiple meta-regression analyses. We’ll also evaluate the risk of selective publication by assessing funnel plot asymmetry and the quality of the evidence by the application of the GRADE recommendations. Discussion This systematic review with meta-analysis aims to assess the repercussion of COVID-19 in pregnant women over maternal-fetal and neonatal outcomes and to help clinicians and health systems improve such population outcomes throughout the current pandemic. Systematic review registration This review protocol was also submitted to PROSPERO registration on February 9, 2021.